Old Web
English
Sign In
Acemap
>
Paper
>
Five-year survival with combined nivolumab and ipilimumab in advanced melanoma: New England Journal of Medicine
Five-year survival with combined nivolumab and ipilimumab in advanced melanoma: New England Journal of Medicine
2019
James Larkin
Vanna Chiarion Sileni
Rene Gonzalez
J.-J. Grob
Piotr Rutkowski
Christopher D. Lao
Charles Lance Cowey
Dirk Schadendorf
John Wagstaff
Reinhard Dummer
Pier Francesco Ferrucci
Michael Smylie
David W. Hogg
Andrew F. Hill
Ivan Marquez Rodas
John B. A. G. Haanen
Massimo Guidoboni
Michele Maio
Patrick Schöffski
M.S. Carlino
Celeste Lebbe
Grant A. McArthur
Paolo A. Ascierto
Gregory A. Daniels
Georgina V. Long
Lars Bastholt
Jasmine I. Rizzo
Agnes Balogh
Andriy Moshyk
F.S. Hodi
Jedd D. Wolchok
Keywords:
new england
advanced melanoma
Internal medicine
Nivolumab
Surgery
Clinical trial
Survival analysis
Ipilimumab
Melanoma
Medicine
Progression-free survival
Oncology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
941
Citations
NaN
KQI
[]